Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing
Metrics: PDF 1874 views | HTML 2827 views | ?
Vikas Patil1,*, Jagriti Pal1,* and Kumaravel Somasundaram1
1 Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India
* These authors have contributed equally to this work
Kumaravel Somasundaram, email:
Keywords: glioblastoma, exome & RNA sequencing, cancer-specific mutations, gene fusions, RNA editing
Received: May 03, 2015 Accepted: October 05, 2015 Published: October 19, 2015
Cell lines derived from tumor tissues have been used as a valuable system to study gene regulation and cancer development. Comprehensive characterization of the genetic background of cell lines could provide clues on novel genes responsible for carcinogenesis and help in choosing cell lines for particular studies. Here, we have carried out whole exome and RNA sequencing of commonly used glioblastoma (GBM) cell lines (U87, T98G, LN229, U343, U373 and LN18) to unearth single nucleotide variations (SNVs), indels, differential gene expression, gene fusions and RNA editing events. We obtained an average of 41,071 SNVs out of which 1,594 (3.88%) were potentially cancer-specific. The cell lines showed frequent SNVs and indels in some of the genes that are known to be altered in GBM- EGFR, TP53, PTEN, SPTA1 and NF1. Chromatin modifying genes- ATRX, MLL3, MLL4, SETD2 and SRCAP also showed alterations. While no cell line carried IDH1 mutations, five cell lines showed hTERT promoter activating mutations with a concomitant increase in hTERT transcript levels. Five significant gene fusions were found of which NUP93-CYB5B was validated. An average of 18,949 RNA editing events was also obtained. Thus we have generated a comprehensive catalogue of genetic alterations for six GBM cell lines.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.